Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net sales (including related party sales of $21,528 and $17,590 in the three months ended March 31, 2020 and 2019, respectively, and $70,974 and $48,849 in the nine months ended March 31, 2020 and 2019, respectively)	$ 772,408	$ 743,499	$ 2,443,155	$ 2,646,126
Cost of sales (including related party purchases of $60,387 and $62,624 in the three months ended March 31, 2020 and 2019, respectively, and $200,753 and $215,331 in the nine months ended March 31, 2020 and 2019, respectively)	639,048	631,172	2,040,462	2,282,638
Gross profit	133,360	112,327	402,693	363,488
Operating expenses:
Research and development	49,586	44,800	154,730	133,718
Sales and marketing	21,886	18,494	64,057	56,463
General and administrative	46,342	36,174	107,680	106,214
Total operating expenses	117,814	99,468	326,467	296,395
Income from operations	15,546	12,859	76,226	67,093
Other income (expense), net	937	(86)	2,110	707
Interest expense	(518)	(1,271)	(1,630)	(5,480)
Income before income tax provision	15,965	11,502	76,706	62,320
Income tax benefit (provision)	899	(497)	(9,782)	(10,540)
Share of loss from equity investee, net of taxes	(1,057)	(359)	(1,066)	(3,572)
Net income	$ 15,807	$ 10,646	$ 65,858	$ 48,208
Net income per common share:
Basic (in dollars per share)	$ 0.31	$ 0.21	$ 1.30	$ 0.97
Diluted (in dollars per share)	$ 0.29	$ 0.21	$ 1.26	$ 0.94
Weighted-average shares used in calculation of net income per common share:
Basic (in shares)	51,526	49,988	50,591	49,845
Diluted (in shares)	53,693	51,558	52,399	51,557